Hollis, Robert L <br/><br/>
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.  [electronic resource] 

 -  Cancer  08 2019 
 - 2772-2781 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.32079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>BRCA2 Protein--genetics<br/>Bevacizumab--administration & dosage<br/>Carboplatin--administration & dosage<br/>Cohort Studies<br/>Computer Simulation<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Nuclear Proteins--genetics<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Repressor Proteins--genetics<br/>Reproducibility of Results